http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-575745-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e559abcd8f120b071dc1162360867ffa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-34
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-52
filingDate 2007-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7816a2dd1a68b01cd1a33f87e18b57a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_954034b0551d3669992be0e32d0d8162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9e36c36ade48d21a10b9f11e46b513e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_138b5c7a2c5f62df51543c5dfc9c5bb9
publicationDate 2010-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-575745-A
titleOfInvention Preparation of azoxystrobin
abstract Disclosed is a process for preparing a compound of formula (I) such as azoxystrobin, which comprises either (a) reacting a compound of formula (II) with 2-cyanophenol, or a salt thereof, in the presence of between 0.1 and 40 mol % of 1,4-diazabicyclo[2.2.2]octane (DABCO), or (b) reacting a compound of the formula (III), with a compound of the formula (IV) or a salt thereof, in the presence of between 0.1 and 40 mol % of 1,4-diazabicyclo[2.2.2]octane; wherein W is the methyl (E)-2-(3-methoxy)acrylate group C(CO2CH3)=CHOCH3 or the methyl 2-(3,3-dimethoxy)propanoate group C(CO2CH3)CH(OCH3)2, or a mixture of the two groups, and wherein 1,4-diazabicyclo[2.2.2]octane is not mixed with the compound of formula (II) or the compound of formula (III) unless (i) 2-cyanophenol or the compound of formula (IV) is present; or (ii) 1,4-diazabicyclo[2.2.2]octane is present as an acid salt or (iii) conditions are such that 1,4-diazabicyclo[2.2.2]octane and the compound of formula (II) or the compound of formula (III) are not able to react with each other; with the proviso that when between 0.1 and 2 mol% 1,4-diazabicyclo[2.2.2]octane is used, the 1,4-diazabicyclo[2.2.2]octane is not added last.
priorityDate 2006-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034285
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453698728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453171762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420533490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61247
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448098817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033859
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9237
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408978442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73806114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428548064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421254664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412224690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413696197
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453375181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7967
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421127813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21934425
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415794077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3587356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413807576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419478284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415748225
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455151449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11782200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558771
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451392314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430

Total number of triples: 66.